Charles Schwab’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.39M | Sell |
|
|||||
|
2025
Q2 | $3.28M | Buy |
|
|||||
|
2025
Q1 | $3.21M | Sell |
|
|||||
|
2024
Q4 | $5.25M | Buy |
|
|||||
|
2024
Q3 | $7.1M | Buy |
|
|||||
|
2024
Q2 | $6.46M | Buy |
|
|||||
|
2024
Q1 | $4.39M | Buy |
|
|||||
|
2023
Q4 | $2.51M | Buy |
|
|||||
|
2023
Q3 | $2.08M | Buy |
|
|||||
|
2023
Q2 | $2M | Sell |
|
|||||
|
2023
Q1 | $1.92M | Sell |
|
|||||
|
2022
Q4 | $2.33M | Buy |
|
|||||
|
2022
Q3 | $2.79M | Buy |
|
|||||
|
2022
Q2 | $2.38M | Buy |
|
|||||
|
2022
Q1 | $1.87M | Buy |
|
|||||
|
2021
Q4 | $2.69M | Buy |
|
|||||
|
2021
Q3 | $3.85M | Buy |
|
|||||
|
2021
Q2 | $2.31M | Buy |
|
|||||
|
2021
Q1 | $3.6M | Buy |
|